These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 436073)

  • 21. D-penicillamine.
    Jaffe IA
    Bull Rheum Dis; 1977-1978; 28(6):948-52. PubMed ID: 630162
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our experience with D penicillamine in the treatment of rheumatoid polyarthritis].
    D'Eshougues JR; Delcambre B; Siame JL; Barbot V; Brion M; Duquesnoy B; Alsac J; Dulieu R
    Lille Med; 1978 Apr; 23(4):259-63. PubMed ID: 651557
    [No Abstract]   [Full Text] [Related]  

  • 23. Fatal cholestatic hepatitis caused by D-penicillamine.
    Jacobs JW; Van der Weide FR; Kruijsen MW
    Br J Rheumatol; 1994 Aug; 33(8):770-3. PubMed ID: 8055207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related nephrotic syndrome in penicillamine-treated rheumatoid arthritis.
    Spiera H
    Mt Sinai J Med; 1984 Dec; 51(6):695-6. PubMed ID: 6335562
    [No Abstract]   [Full Text] [Related]  

  • 26. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adverse effects of D-penicillamine in rheumatoid arthritis with reference to prior gold therapy].
    Ishihara Y; Fujita A; Ohdoi S; Saitoh K; Katsube S; Azuma T
    Ryumachi; 1985 Feb; 25(1):15-9. PubMed ID: 4002060
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 30. [3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine].
    Renier JC; Bontoux-Carre E; Racineux JL
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):25-6. PubMed ID: 3704508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
    Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T
    Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of common rheumatoid polyarthritis with D-penicillamine].
    Camus JP; Bénichou C; Guillien P; Crouzet J; Lièvre JA
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):809-20. PubMed ID: 5152714
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of cholestatic hepatitis associated with D-penicillamine therapy for rheumatoid arthritis.
    Devogelaer JP; Huaux JP; Coche E; Rahier J; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(1):35-8. PubMed ID: 3997313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic thrombocytopenic purpura associated with D-penicillamine treatment in rheumatoid arthritis.
    Speth PA; Boerbooms AM; Holdrinet RS; Van de Putte LB; Meyer JW
    J Rheumatol; 1982; 9(5):812-3. PubMed ID: 6890995
    [No Abstract]   [Full Text] [Related]  

  • 37. [Penicillamine in 1985].
    Camus JP; Koeger AC; Laveant C; Leca AP
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):1-5. PubMed ID: 3518031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Obliterating bronchiolitis in rheumatoid arthritis. Responsibility of D-penicillamine].
    Herne N; Jaubert D; Camilleri G; Prieur J
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):744. PubMed ID: 7313490
    [No Abstract]   [Full Text] [Related]  

  • 39. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.